{"article_title": "The world's first artificial pancreas goes to a 4-year-old boy in Australia", "article_keywords": ["worlds", "australia", "insulin", "boy", "hospital", "pump", "artificial", "sugar", "4yearold", "levels", "pumps", "blood", "goes", "device", "pancreas"], "article_url": "http://medcitynews.com/2015/01/worlds-first-artificial-pancreas-goes-4-year-old-boy-australia/", "article_text": "A 4-year-old boy in Australia, Xavier Hames, just received the first artificial pancreas device from Princess Margaret Hospital for Children, which will regulate his insulin levels for him.\n\nThe hospital was where clinical trials for the device have been taking place for several years, and now it\u2019s available for $8,100. This is big news for the many people in the world who have diabetes. In fact, just in 2013 over 79,000 children around the globe were diagnosed with type 1 diabetes.\n\nInsulin therapy is tricky with pumps or injections because it\u2019s difficult to get levels where you want them at all times of the day and night.\n\nIFLScience explained how the device works \u2013 it\u2019s pretty cool:\n\nAdvertisement\n\nThe artificial pancreas features a sensor that reads blood sugar levels and communicates to the pump, which is connected to the body underneath the skin to administer the insulin. Unlike traditional pumps, this new technology does not deliver a constant stream of insulin to the body. Instead, the artificial pancreas uses an algorithm to track blood sugar levels over time, predicting when insulin is no longer required. This reduces the risk of dangerously low blood sugar levels, known as hypoglycemia.\n\n\u201cThe majority of hypoglycemic attacks occur at night when a person is asleep and they might not be able to react or recognize the attack,\u201d Professor Tim Jones from Princess Margaret Hospital told The West Australian. \u201cThis device can predict hypoglycemia before it happens and stop insulin delivery before a predicted event. This, coupled with the fact that the pump automatically resumes insulin when glucose levels recover, is a real medical breakthrough.\u201d", "article_metadata": {"description": "A 4-year-old boy in Australia,\u00a0Xavier Hames, just received the first artificial pancreas\u00a0device from Princess Margaret Hospital for Children, which will regulate his insulin levels for him. The hospital was where clinical trials for the device have been taking place for several years, and now it\u2019s available for $8,100. This is big news for the many people in the world who have diabetes. In fact, just in 2013 over 79,000 children around the globe were diagnosed with type 1 diabetes. Insulin therapy is tricky with pumps or injections because it\u2019s difficult to get levels where you want them at all times of the day and night. IFLScience explained how the device works \u2013 it\u2019s pretty cool: The artificial pancreas features a sensor that reads blood sugar levels and communicates to the pump, which is connected to the body underneath the skin to administer the insulin. Unlike traditional pumps, this new technology does not deliver a constant stream of insulin to the body. Instead, the artificial pancreas uses an algorithm to track blood sugar levels over time, predicting when insulin is no longer required. This reduces the risk of dangerously low blood sugar levels, known as hypoglycemia. \u201cThe majority of hypoglycemic attacks occur at night when a person is asleep and they might not be able to react or recognize the attack,\u201d Professor Tim Jones from Princess Margaret Hospital told The West Australian. \u201cThis device can predict hypoglycemia before it happens and stop insulin delivery before a predicted event. This, coupled with the fact that the pump automatically resumes insulin when glucose levels recover, is a real medical breakthrough.\u201d", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "A 4-year-old boy in Australia,\u00a0Xavier Hames, just received the first artificial pancreas\u00a0device from Princess Margaret Hospital for Children, which will regulate his insulin levels for him. The hospital was where clinical trials for the device have been taking place for several years, and now it\u2019s available for $8,100. This is big news for the many people in the world who have diabetes. In fact, just in 2013 over 79,000 children around the globe were diagnosed with type 1 diabetes. Insulin therapy is tricky with pumps or injections because it\u2019s difficult to get levels where you want them at all times of the day and night. IFLScience explained how the device works \u2013 it\u2019s pretty cool: The artificial pancreas features a sensor that reads blood sugar levels and communicates to the pump, which is connected to the body underneath the skin to administer the insulin. Unlike traditional pumps, this new technology does not deliver a constant stream of insulin to the body. Instead, the artificial pancreas uses an algorithm to track blood sugar levels over time, predicting when insulin is no longer required. This reduces the risk of dangerously low blood sugar levels, known as hypoglycemia. \u201cThe majority of hypoglycemic attacks occur at night when a person is asleep and they might not be able to react or recognize the attack,\u201d Professor Tim Jones from Princess Margaret Hospital told The West Australian. \u201cThis device can predict hypoglycemia before it happens and stop insulin delivery before a predicted event. This, coupled with the fact that the pump automatically resumes insulin when glucose levels recover, is a real medical breakthrough.\u201d", "title": "The world\u2019s first artificial pancreas goes to a 4-year-old boy in Australia", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/stomach-pancreas-liver.jpg", "updated_time": "2015-01-23T09:28:34-04:00", "url": "http://medcitynews.com/2015/01/worlds-first-artificial-pancreas-goes-4-year-old-boy-australia/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/stomach-pancreas-liver.jpg", "description": "A 4-year-old boy in Australia,\u00a0Xavier Hames, just received the first artificial pancreas\u00a0device from Princess Margaret Hospital for Children, which will regulate his insulin levels for him. The hospital was where clinical trials for the device have been taking place for several years, and now it\u2019s available for $8,100. This is big news for the many people in the world who have diabetes. In fact, just in 2013 over 79,000 children around the globe were diagnosed with type 1 diabetes. Insulin therapy is tricky with pumps or injections because it\u2019s difficult to get levels where you want them at all times of the day and night. IFLScience explained how the device works \u2013 it\u2019s pretty cool: The artificial pancreas features a sensor that reads blood sugar levels and communicates to the pump, which is connected to the body underneath the skin to administer the insulin. Unlike traditional pumps, this new technology does not deliver a constant stream of insulin to the body. Instead, the artificial pancreas uses an algorithm to track blood sugar levels over time, predicting when insulin is no longer required. This reduces the risk of dangerously low blood sugar levels, known as hypoglycemia. \u201cThe majority of hypoglycemic attacks occur at night when a person is asleep and they might not be able to react or recognize the attack,\u201d Professor Tim Jones from Princess Margaret Hospital told The West Australian. \u201cThis device can predict hypoglycemia before it happens and stop insulin delivery before a predicted event. This, coupled with the fact that the pump automatically resumes insulin when glucose levels recover, is a real medical breakthrough.\u201d", "card": "summary", "title": "The world's first artificial pancreas goes to a 4-year-old boy in Australia - MedCity News"}, "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,artificial pancreas, Diabetes, Princess Margaret Hospital for Children, Tim Jones, Xavier Hames, , MedCity News", "article": {"section": "Daily", "tag": "Xavier Hames", "published_time": "2015-01-23T09:28:04-04:00", "modified_time": "2015-01-23T09:28:34-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "A 4-year-old boy in Australia, Xavier Hames, just received the first artificial pancreas device from Princess Margaret Hospital for Children, which will regulate his insulin levels for him.\nInstead, the artificial pancreas uses an algorithm to track blood sugar levels over time, predicting when insulin is no longer required.\nThis reduces the risk of dangerously low blood sugar levels, known as hypoglycemia.\nThis, coupled with the fact that the pump automatically resumes insulin when glucose levels recover, is a real medical breakthrough.\u201d\nThe hospital was where clinical trials for the device have been taking place for several years, and now it\u2019s available for $8,100."}